Publications 2015
217.
Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.
Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.
PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015.
216.
Cisek K, Krochmal M, Klein J, Mischak H.
The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Sleep Sci. 2015 Apr-Jun;8(2):58-67. doi: 10.1016/j.slsci.2015.06.004. Epub 2015 Jul 17.
215.
Seetho IW, Ramírez-Torres A, Albalat A, Mullen W, Mischak H, Parker RJ, Craig S, Duffy N, Hardy KJ, Burniston JG, Wilding JP.
Urinary proteomic profiling in severe obesity and obstructive sleep apnoea with CPAP treatment.
Sleep Sci. 2015 Apr-Jun;8(2):58-67. doi: 10.1016/j.slsci.2015.06.004. Epub 2015 Jul 17.
214.
Nkuipou-Kenfack E, Bhat A, Klein J, Jankowski V, Mullen W, Vlahou A, Dakna M, Koeck T, Schanstra JP, Zürbig P, Rudolph KL, Schumacher B, Pich A, Mischak H.
Identification of ageing-associated naturally occurring peptides in human urine.
Oncotarget. 2015 Sep 29. [Epub ahead of print].
213.
Latosinska A, Vougas K, Makridakis M, Klein J, Mullen W, Abbas M, Stravodimos K, Katafigiotis I, Merseburger AS, Zoidakis J, Mischak H, Vlahou A, Jankowski V.
Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.
PLoS One. 2015 Sep 2;10(9):e0137048. doi: 10.1371/journal.pone.0137048. eCollection 2015.
212.
Pena MJ, de Zeeuw D, Mischak H, Jankowski J, Oberbauer R, Woloszczuk W, Benner J, Dallmann G, Mayer B, Mayer G, Rossing P, Lambers Heerspink HJ.
Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.
Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv86-iv95. doi: 10.1093/ndt/gfv252. Review.
211.
Jankowski J, Schanstra JP, Mischak H.
Body fluid peptide and protein signatures in diabetic kidney diseases.
Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv43-iv53. doi: 10.1093/ndt/gfv091. Review.
210.
Filip S, Vougas K, Zoidakis J, Latosinska A, Mullen W, Spasovski G, Mischak H, Vlahou A, Jankowski J.
Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.
PMID: 26208298 Free PMC Article
209.
Øvrehus MA, Zürbig P, Vikse BE, Hallan SI.
Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria.
Clin Proteom (2015) 12:21. doi: 10.1186/s12014-015-9092-7
208.
Glorieux G, Mullen W, Duranton F, Filip S, Gayrard N, Husi H, Schepers E, Neirynck N, Schanstra JP, Jankowski J, Mischak H, Argilés À, Vanholder R, Vlahou A, Klein J.
New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis.
Nephrol Dial Transplant. 2015 Jul 9. pii: gfv254. [Epub ahead of print]
207.
Zhang ZY, Thijs L, Petit T, Gu YM, Jacobs L, Yang WY, Liu YP, Koeck T, Zürbig P, Jin Y, Verhamme P, Voigt JU, Kuznetsova T, Mischak H, Staessen JA.
Urinary Proteome and Systolic Blood Pressure as Predictors of 5-Year Cardiovascular and Cardiac Outcomes in a General Population.
Hypertension. 2015 Jul;66(1):52-60. doi: 10.1161/HYPERTENSIONAHA.115.05296. Epub 2015 May 11.
206.
Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A.
Developing proteomic biomarkers for bladder cancer: towards clinical application.
Nat Rev Urol. 2015 Jun;12(6):317-330. doi: 10.1038/nrurol.2015.100. Epub 2015 May 26. Review.
205.
Pejchinovski M, Klein J, Ramírez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Mullen W, Mischak H, Jankowski V.
Comparison of higher-energy collisional dissociation and collision-induced dissociation MS/MS sequencing methods for identification of naturally occurring peptides in human urine.
Proteomics Clin Appl. 2015 Mar 27. doi: 10.1002/prca.201400163. [Epub ahead of print]
204.
Mischak H
Pro: Urine proteomics as a liquid kidney biopsy: no more kidney punctures!
Nephrol. Dial. Transplant. (2015) 30 (4): 532-537 doi:10.1093/ndt/gfv046
203.
Mischak H
Opponent's comments.
Nephrol Dial Transplant. 2015 Apr;30(4):531-2. doi: 10.1093/ndt/gfv044a. No abstract available.
202.
Mischak H, Critselis E, Hanash S, Gallagher WM, Vlahou A, Ioannidis JP.
Epidemiologic Design and Analysis for Proteomic Studies: A Primer on -Omic Technologies.
Am J Epidemiol. 2015 May 1;181(9):635-47. doi: 10.1093/aje/kwu462. Epub 2015 Mar 19.
201.
Gleiss A, Dakna M, Mischak H, Heinze G.
Two-group comparisons of zero-inflated intensity values: the choice of test statistic matters.
Bioinformatics. 2015 Mar 18. pii: btv154. [Epub ahead of print]
200.
Brown CE, McCarthy NS, Hughes AD, Sever P, Stalmach A, Mullen W, Dominiczak AF, Sattar N, Mischak H, Thom S, Mayet J, Stanton AV, Delles C.
Urinary proteomic biomarkers to predict cardiovascular events.
Proteomics Clin Appl. 2015 Mar 19. doi: 10.1002/prca.201400195. [Epub ahead of print]
199.
Nally JE, Mullen W, Callanan JJ, Mischak H, Albalat A.
Detection of urinary biomarkers in reservoir hosts of leptospirosis by capillary electrophoresis mass spectrometry.
Proteomics Clin Appl. 2015 Mar 3. doi: 10.1002/prca.201400205. [Epub ahead of print]
198.
Mischak H, Delles C, Vlahou A, Vanholder R.
Proteomic biomarkers in kidney disease: issues in development and implementation.
Nat Rev Nephrol. 2015 Apr;11(4):221-32. doi: 10.1038/nrneph.2014.247. Epub 2015 Feb 3. Review.
197.
Pontillo C, Filip S, Borràs DM, Mullen W, Vlahou A, Mischak H. Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400115. [Epub ahead of print]
CE-MS-based proteomics in biomarker discovery and clinical application.
Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400115. [Epub ahead of print]
196.
Pejchinovski M, Hrnjez D, Ramírez-Torres A, Bitsika V, Mermelekas G, Vlahou A, Zürbig P, Mischak H, Metzger J, Koeck T.
Capillary zone electrophoresis on-line coupled to mass spectrometry: a perspective application for clinical proteomics.
Proteomics Clin Appl. 2015 Jan 16. doi: 10.1002/prca.201400113. [Epub ahead of print]
195.
Schanstra JP, Zürbig P, Alkhalaf A, Argiles A, Bakker SJ, Beige J, Bilo HJ, Chatzikyrkou C, Dakna M, Dawson J, Delles C, Haller H, Haubitz M, Husi H, Jankowski J, Jerums G, Kleefstra N, Kuznetsova T, Maahs DM, Menne J, Mullen W, Ortiz A, Persson F, Rossing P, Ruggenenti P, Rychlik I, Serra AL, Siwy J, Snell-Bergeon J, Spasovski G, Staessen JA, Vlahou A, Mischak H, Vanholder R. J
Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.
J Am Soc Nephrol. 2015 Jan 14. pii: ASN.2014050423. [Epub ahead of print]
194.
Bhat A, Heinzel A, Mayer B, Perco P, Mühlberger I, Husi H, Merseburger AS, Zoidakis J, Vlahou A, Schanstra JP, Mischak H, Jankowski V.
Protein interactome of muscle invasive bladder cancer.
PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015.